April 27, 2012
Jazz Pharmaceuticals is the latest drugmaker to hit the acquisition trail with its proposed purchase of Eusa Pharma and its leukaemia therapy Erwinaze
Full story
November 21, 2011
Regeneron Pharmaceuticals and Eusa Pharma have been boosted by the news that regulators in the USA have approved a blindness drug and a leukaemia therapy, respectively